Integral Diagnostics Ltd ITGDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.96
- Day Range
- $1.40–1.40
- 52-Week Range
- $0.96–1.40
- Bid/Ask
- $0.51 / $2.10
- Market Cap
- $326.86 Mil
- Volume/Avg
- 110 / 704
Key Statistics
- Price/Earnings (Normalized)
- 24.31
- Price/Sales
- 1.09
- Dividend Yield (Trailing)
- 2.74%
- Dividend Yield (Forward)
- 1.50%
- Total Yield
- 2.74%
Company Profile
Integral Diagnostics is Australia’s fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,749
Competitors
Valuation
Metric
|
ITGDF
|
HLS
|
SHL
|
---|---|---|---|
Price/Earnings (Normalized) | 24.31 | 2.26 | 24.21 |
Price/Book Value | 1.60 | 0.79 | 1.61 |
Price/Sales | 1.09 | 0.41 | 1.48 |
Price/Cash Flow | 7.99 | 2.45 | 10.87 |
Price/Earnings
ITGDF
HLS
SHL
Financial Strength
Metric
|
ITGDF
|
HLS
|
SHL
|
---|---|---|---|
Quick Ratio | 0.47 | 0.44 | 0.78 |
Current Ratio | 0.76 | 0.53 | 0.94 |
Interest Coverage | −1.55 | −13.26 | 5.95 |
Quick Ratio
ITGDF
HLS
SHL
Profitability
Metric
|
ITGDF
|
HLS
|
SHL
|
---|---|---|---|
Return on Assets (Normalized) | −0.84% | 0.10% | 4.07% |
Return on Equity (Normalized) | −1.95% | 0.23% | 7.01% |
Return on Invested Capital (Normalized) | 1.08% | 2.27% | 4.52% |
Return on Assets
ITGDF
HLS
SHL
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Blmwnnrhf | Qqxr | $218.5 Bil | |
DHR
| Danaher Corp | Dsbfckgp | Ybkcjs | $184.0 Bil | |
A
| Agilent Technologies Inc | Hqtvnxvf | Grw | $40.9 Bil | |
IQV
| IQVIA Holdings Inc | Zfxywyk | Yhwjcbf | $40.7 Bil | |
IDXX
| IDEXX Laboratories Inc | Fbmdsmgrd | Czbdl | $39.7 Bil | |
MTD
| Mettler-Toledo International Inc | Nskyftgvjr | Sbncx | $26.8 Bil | |
ICLR
| Icon PLC | Xcmxyyhs | Xtqpjf | $25.6 Bil | |
WAT
| Waters Corp | Grldqwyxnq | Pnly | $19.1 Bil | |
ILMN
| Illumina Inc | Xsnknjhz | Lcxkz | $18.8 Bil | |
LH
| Laboratory Corp of America Holdings | Xkqsrbdcjt | Syhpdk | $17.0 Bil |